Virtual Reality-based Eye Movement Desensitisation and Reprocessing Therapy for Specific Phobias
NCT ID: NCT06906770
Last Updated: 2025-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2025-04-28
2025-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
Does the VR EMDR application reduce distress, improve positive cognitions, and decrease avoidance of specific phobias? Can the application help diminish phobia-related bodily sensations and encourage cognitive shifts toward positive beliefs and greater confidence in confronting previously avoided situations? Can the participants independently administer the treatment with minimum assistance?
Participants will:
Visit the site and take the VR EMDR phobia treatment every day for one week. Report their phobia and simulator sickness symptoms through self-report questionnaires or semi-structured interviews.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Protocol for a Virtual Reality Exposure Therapy for Fear of Flying.
NCT05939986
EMDR in Spider Phobia: Work Mechanisms and Treatment Outcome
NCT02973919
Virtual Reality Exposure Therapy in Agoraphobic Participants
NCT00734370
Use of Augmented Reality and Virtual Reality During Cognitive Behavioral Therapy for Needle Phobia
NCT07042074
Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software
NCT03001154
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VR EMDR
Eye movement desensitization and reprocessing phobia treatment in virtual reality
Short form and frequent eye movement desensitization and reprocessing (EMDR) in virtual reality for specific phobia treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye movement desensitization and reprocessing phobia treatment in virtual reality
Short form and frequent eye movement desensitization and reprocessing (EMDR) in virtual reality for specific phobia treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of trauma associated with their phobia
* History of panic attacks associated with their phobia
* History of psychosis
* Current self-harm
* Current suicidal ideation
* Regular use of substances that might affect mental state
* Regular use of medications that might affect mental state
* Significant visual impairments
* Severe motion sickness
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St Andrew's Healthcare
OTHER
The University of Northampton
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Northampton
Northampton, Northamptonshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FHSHEA000372
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.